60
Participants
Start Date
May 1, 2020
Primary Completion Date
July 10, 2020
Study Completion Date
September 23, 2020
COVID-19 convalescent hyperimmune plasma
Subjects to receive double convalescent hyperimmune plasma units of 300 ml each, with the 2nd unit administered no later than 24 hrs after the first one
Non-convalescent fresh frozen plasma (Standard plasma)
Subjects to receive double standard plasma units of 300 ml each, with the 2nd unit administered no later than 24 hrs after the first one
Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
OTHER_GOV